Salix Pharmaceuticals, Inc.
Records under this name other than the patents Salix Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 50 patents it holds.
Back to Salix Pharmaceuticals, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US D715,422 | Automatic Injection Device Formerly held In force · High confidence | In force | High confidence | |
| US 9,359,357 | Forms of Rifaximin and Uses Thereof Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 9,181,274 | Forms of Rifaximin and Uses Thereof Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 8,962,680 | Methods and Compositions for Treating HIV-Associated Diarrhea Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 9,585,868 | Methods and Compositions for Treating HIV-Associated Diarrhea Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 10,092,573 | Gastric and Colonic Formulations and Methods for Making and Using Them Formerly held In force · High confidence | In force | High confidence | |
| US 8,507,517 | Forms of Rifaximin and Uses Thereof Formerly held In force · High confidence | In force | High confidence | |
| US 9,364,467 | Rifaximin Derivative and Uses Thereof Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 9,725,466 | Rifaximin Derivative and Uses Thereof Formerly held In force · Low confidence | In force | Low confidence | |
| US 7,452,872 | Formulations and Uses of 2-Hydroxy-5-Phenylazobenzoic Acid Derivatives Term ended Term ended Aug 24, 2026 · Medium confidence | Term ended | Term ended Aug 24, 2026 | Medium confidence |